Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alcohol dehydrogenase 1A (ADH1A) is a key enzyme of the alcohol dehydrogenase family, functioning as the alpha subunit of class I alcohol dehydrogenase, and catalyzing the NAD+-dependent oxidation of alcohols to aldehydes[1][2]. It is highly active in the oxidation of ethanol (major pathway for alcohol catabolism in the liver), as well as in the oxidation of retinol to retinaldehyde (an essential step in vitamin A metabolism)[1]. The gene encoding ADH1A is predominantly expressed in fetal and infant liver and is part of a gene cluster on chromosome 4 that also includes genes encoding the beta and gamma subunits[2]. ADH1A shows high sequence similarity to other class I alcohol dehydrogenases but differs in its substrate specificity and developmental expression. Genetic variation within ADH1A and related genes influences susceptibility to alcohol dependence and certain alcohol-induced diseases such as gastric cancer[1]. Therapeutically, ADH1A is an important molecular target for alcohol poisoning interventions (e.g., inhibition by 4-methylpyrazole) and is implicated in the modulation of neurobehavioral and metabolic responses to alcohol.
Catalyzes the NAD+-dependent oxidation of ethanol and other alcohols to aldehydes 4-methylpyrazole acts as a competitive inhibitor of ADH1A by binding to its active site and blocking the oxidation of alcohol substrates[3]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alcohol dehydrogenase 1A (class I), alpha polypeptide (ADH1A).